TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 2nMAssay Description:Binding affinity to VEGFR1 (unknown origin)More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 14nMAssay Description:Inhibition of recombinant FLT1 after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATPMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 27.1nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 29.6nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 29.6nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 30.3nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 30.7nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 30.7nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 31.4nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 31.4nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 31.6nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 31.6nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 36.2nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 36.2nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 41.6nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 41.6nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 41.6nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 41.6nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 42.6nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 42.6nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 44.7nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 45.4nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 45.4nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 47.7nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 47.7nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 49nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 49.7nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 49.7nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 50nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 50nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 52.3nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 52.3nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 52.3nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 52.3nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 52.7nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 52.7nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 56.1nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 57.5nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 57.5nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 57.5nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 60nMAssay Description:Inhibitory activity against VEGFR1More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 61.9nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 61.9nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 63.2nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 63.2nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 63.7nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 65.1nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 65.1nMAssay Description:Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 66.7nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 1(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 66.9nMAssay Description:The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...More data for this Ligand-Target Pair